Alpha DNA Investment Management’s Meritage Homes MTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,438
Closed -$495K 111
2024
Q4
$495K Buy
6,438
+380
+6% +$34.7K 0.19% 106
2024
Q3
$621K Buy
6,058
+724
+14% +$68.4K 0.23% 94
2024
Q2
$432K Buy
5,334
+1,250
+31% +$105K 0.17% 140
2024
Q1
$358K Buy
4,084
+476
+13% +$38.5K 0.13% 177
2023
Q4
$314K Buy
+3,608
New +$249K 0.12% 161

Other funds holding MTH

Alpha DNA Investment Management's MTH Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Meritage Homes (MTH) in Q1 2025, closing a stake of 6,438 shares — an estimated $495K sold.

Alpha DNA Investment Management first reported a position in MTH in Q4 2023 and held it in 5 quarters. The position peaked at $621K in Q3 2024. 391 funds tracked by Wall St. Rank hold MTH as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Meritage Homes position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 6,438 Meritage Homes shares in Q1 2025, an estimated $495K.
  • Alpha DNA Investment Management first reported a position in Meritage Homes in Q4 2023 and held it in 5 quarters.
  • Alpha DNA Investment Management's Meritage Homes position peaked at $621K in Q3 2024.
  • 391 funds tracked by Wall St. Rank held Meritage Homes as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.